Login
Home
Charts
Search
Watchlist
Products

Bharat Rasayan Ltd

BHARATRAS·NSE
1,134.00+0.41%Wed, 23 Sept '26

Bharat Rasayan Ltd

BHARATRAS
NSE
1,134.00
+0.41%
|Wed, 23 Sept '26
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
1,885Cr
Close
Close Price
1,134.00
Industry
Industry
Pesticides/Agrochemicals
PE
Price To Earnings
13.15
PS
Price To Sales
1.57
Revenue
Revenue
1,203Cr
Rev Gr TTM
Revenue Growth TTM
-5.17%
PAT Gr TTM
PAT Growth TTM
4.24%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
263233310282328256307377286270308338
Growth YoY
Revenue Growth YoY%
-9.9-24.71.218.024.710.1-1.033.7-12.85.50.5-10.4
Expenses
ExpensesCr
248205240244273215266304253228258287
Operating Profit
Operating ProfitCr
152869385542407333435051
OPM
OPM%
5.512.022.413.516.716.313.119.411.615.816.315.0
Other Income
Other IncomeCr
222222-1183-12111796
Interest Expense
Interest ExpenseCr
111111111111
Depreciation
DepreciationCr
676667766777
PBT
PBTCr
102284534652355436525149
Tax
TaxCr
46171014119148121312
PAT
PATCr
61567433241254028403837
Growth YoY
PAT Growth YoY%
-73.8-54.7121.8508.2435.7164.7-62.5-8.0-13.3-1.251.8-6.1
NPM
NPM%
2.36.621.715.39.815.88.210.59.814.812.411.0
EPS
EPS
3.69.240.425.919.324.415.123.916.824.122.922.4
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
263233310282328256307377286270308338
Growth YoY
Revenue Growth YoY%
-9.9-24.71.218.024.710.1-1.033.7-12.85.50.5-10.4
Expenses
ExpensesCr
248205240244273215266304253228258287
Operating Profit
Operating ProfitCr
152869385542407333435051
OPM
OPM%
5.512.022.413.516.716.313.119.411.615.816.315.0
Other Income
Other IncomeCr
222222-1183-12111796
Interest Expense
Interest ExpenseCr
111111111111
Depreciation
DepreciationCr
676667766777
PBT
PBTCr
102284534652355436525149
Tax
TaxCr
46171014119148121312
PAT
PATCr
61567433241254028403837
Growth YoY
PAT Growth YoY%
-73.8-54.7121.8508.2435.7164.7-62.5-8.0-13.3-1.251.8-6.1
NPM
NPM%
2.36.621.715.39.815.88.210.59.814.812.411.0
EPS
EPS
3.69.240.425.919.324.415.123.916.824.122.922.4

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
9921,2151,0921,3011,2341,0451,1731,2421,203
Growth
Revenue Growth%
22.4-10.119.1-5.1-15.412.35.9-5.2
Expenses
ExpensesCr
8059868521,0501,0379279981,0431,026
Operating Profit
Operating ProfitCr
187229240251197117175199177
OPM
OPM%
18.918.921.919.316.011.214.916.014.7
Other Income
Other IncomeCr
114514935422543
Interest Expense
Interest ExpenseCr
16164763554
Depreciation
DepreciationCr
172226252626272627
PBT
PBTCr
155205215234174123185193188
Tax
TaxCr
444851584928444845
PAT
PATCr
11215816417612596141146143
Growth
PAT Growth%
41.44.07.4-29.2-23.447.53.44.2
NPM
NPM%
11.213.015.013.510.19.112.011.711.9
EPS
EPS
65.692.896.4105.975.057.584.887.786.2
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
9921,2151,0921,3011,2341,0451,1731,2421,203
Growth
Revenue Growth%
22.4-10.119.1-5.1-15.412.35.9-5.2
Expenses
ExpensesCr
8059868521,0501,0379279981,0431,026
Operating Profit
Operating ProfitCr
187229240251197117175199177
OPM
OPM%
18.918.921.919.316.011.214.916.014.7
Other Income
Other IncomeCr
114514935422543
Interest Expense
Interest ExpenseCr
16164763554
Depreciation
DepreciationCr
172226252626272627
PBT
PBTCr
155205215234174123185193188
Tax
TaxCr
444851584928444845
PAT
PATCr
11215816417612596141146143
Growth
PAT Growth%
41.44.07.4-29.2-23.447.53.44.2
NPM
NPM%
11.213.015.013.510.19.112.011.711.9
EPS
EPS
65.692.896.4105.975.057.584.887.786.2

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
44444448
Reserves
ReservesCr
4055607237668899841,1261,266
Current Liabilities
Current LiabilitiesCr
293153170304171197261136
Non Current Liabilities
Non Current LiabilitiesCr
5434101110131721
Total Liabilities
Total LiabilitiesCr
7567529081,0861,0741,1971,4081,433
Current Assets
Current AssetsCr
5645196507977919071,0931,060
Non Current Assets
Non Current AssetsCr
192233258289283291315372
Total Assets
Total AssetsCr
7567529081,0861,0741,1971,4081,433
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
44444448
Reserves
ReservesCr
4055607237668899841,1261,266
Current Liabilities
Current LiabilitiesCr
293153170304171197261136
Non Current Liabilities
Non Current LiabilitiesCr
5434101110131721
Total Liabilities
Total LiabilitiesCr
7567529081,0861,0741,1971,4081,433
Current Assets
Current AssetsCr
5645196507977919071,0931,060
Non Current Assets
Non Current AssetsCr
192233258289283291315372
Total Assets
Total AssetsCr
7567529081,0861,0741,1971,4081,433

Cash Flow

Consolidated
Standalone
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-52263170-6521341172132
Investing Cash Flow
Investing Cash FlowCr
-48-68-15351-61-90-157-96
Financing Cash Flow
Financing Cash FlowCr
102-169-40-25-15249-1-89
Net Cash Flow
Net Cash FlowCr
440-19-26181423-33
Free Cash Flow
Free Cash FlowCr
-100204160-1211911413759
CFO To PAT
CFO To PAT%
-46.9166.6103.9-37.2171.243.0122.190.6
CFO To EBITDA
CFO To EBITDA%
-28.0114.671.0-26.1108.335.098.466.3
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-52263170-6521341172132
Investing Cash Flow
Investing Cash FlowCr
-48-68-15351-61-90-157-96
Financing Cash Flow
Financing Cash FlowCr
102-169-40-25-15249-1-89
Net Cash Flow
Net Cash FlowCr
440-19-26181423-33
Free Cash Flow
Free Cash FlowCr
-100204160-1211911413759
CFO To PAT
CFO To PAT%
-46.9166.6103.9-37.2171.243.0122.190.6
CFO To EBITDA
CFO To EBITDA%
-28.0114.671.0-26.1108.335.098.466.3

Ratios

Consolidated
Standalone
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1,7772,2143,9985,0613,7783,5314,3782,0101,885
Price To Earnings
Price To Earnings
15.914.024.428.830.337.031.113.813.2
Price To Sales
Price To Sales
1.81.83.73.93.13.43.71.61.6
Price To Book
Price To Book
4.33.95.56.64.23.63.91.61.5
EV To EBITDA
EV To EBITDA
10.89.816.820.819.130.425.210.010.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
26.926.331.228.725.523.725.826.926.9
OPM
OPM%
18.918.921.919.316.011.214.916.014.7
NPM
NPM%
11.213.015.013.510.19.112.011.711.9
ROCE
ROCE%
26.133.627.925.519.511.815.615.515.5
ROE
ROE%
27.327.922.522.913.99.712.511.411.4
ROA
ROA%
14.821.018.116.211.68.010.010.210.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1,7772,2143,9985,0613,7783,5314,3782,0101,885
Price To Earnings
Price To Earnings
15.914.024.428.830.337.031.113.813.2
Price To Sales
Price To Sales
1.81.83.73.93.13.43.71.61.6
Price To Book
Price To Book
4.33.95.56.64.23.63.91.61.5
EV To EBITDA
EV To EBITDA
10.89.816.820.819.130.425.210.010.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
26.926.331.228.725.523.725.826.926.9
OPM
OPM%
18.918.921.919.316.011.214.916.014.7
NPM
NPM%
11.213.015.013.510.19.112.011.711.9
ROCE
ROCE%
26.133.627.925.519.511.815.615.515.5
ROE
ROE%
27.327.922.522.913.99.712.511.411.4
ROA
ROA%
14.821.018.116.211.68.010.010.210.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Bharat Rasayan is an Indian manufacturer that makes the active chemicals farmers spray on crops to stop insects, weeds and disease - and it transformed itself from a pure generics player by striking a joint venture with Japan’s Nissan Chemical Corporation, gaining access to proprietary, lower-toxicity technology. The company was founded in 1989 and has always operated in a single business: pesticides. Its recurring approach is to seek out partnerships with Japanese innovators whose chemistry is eco-friendly and safe, then manufacture those molecules at scale from its two plants in Haryana and Gujarat for customers across 28 countries. # Business segments A single engine - manufacturing crop protection chemicals - that runs on two deeply connected activities: making the pure active ingredient and turning it into over 400 ready-to-use formulations for farmers in India and export markets. ## 1. Technical-grade manufacturing: the pure molecule factory **The company makes the concentrated active ingredient that kills the pest - the hardest part of the chemistry - and sells it to formulators or directly to large customers who mix their own end products.** - **Starts with imported intermediates** - the Indian industry depends heavily on chemical building blocks sourced from China, and the company stockpiles raw materials to insulate production from supply-chain disruptions. - **Four signature molecules** - its technical-grade portfolio is built around Lambda Cyhalothrin, Meta Phenoxy Benzaldehyde (MPBD), Metribuzine and Diafenthiuron, several of which were designed with environmental and safety concerns in mind. - **Two-plant manufacturing backbone** - production runs at Mokhra in Haryana and a multi-block facility at Dahej in Gujarat; a fire in Block-D at Dahej in May 2022 was fully rebuilt by February 2024, and the plant now operates at full capacity across all four blocks. - **Solvent recovery cuts cost and waste** - the company recycles up to 95% of its spent solvents - toluene, methanol, iso-propyl alcohol and others - and reuses by-products like HCl and HBr internally, which lowers input costs and reduces environmental load. - **Zero-liquid-discharge discipline** - an effluent treatment plant with multi-effect evaporation and reverse osmosis treats all wastewater and recycles it back into cooling towers and processes, so nothing leaves the site as liquid discharge. ## 2. Formulations: the farmer-ready product engine **The company takes its own technical-grade molecules - and those it buys - and mixes them into over 400 spray-can, powder and granule products that a farmer can use directly on the field.** - **Breadth across every crop threat** - the portfolio spans insecticides, fungicides, herbicides and plant growth regulators, with herbicides as the largest category, particularly soil-active types that work on seeds and shoots before weeds emerge. - **Combination products are the growth edge** - mixing two or more active ingredients in one bottle is gaining popularity in India because it simplifies application for farmers and slows down pest resistance, extending the commercial life of each molecule. - **Two certified R&D labs run round the clock** - one government-certified facility at Bahadurgarh and one NABL-accredited lab at Dahej, each with its own pilot plant, develop new formulations and next-generation chemistries without any imported technology or outside technical collaboration. - **Seasonal demand tied to the monsoon** - sales rise and fall with rainfall patterns, pest outbreaks and crop cycles, because a farmer’s decision to spray depends directly on how the weather affects his standing crop. - **Sold through dealers, not to farmers directly** - products reach end customers via a network of distributors and dealers in India, while export sales - particularly to Latin America and Southeast Asia - are made directly to overseas buyers. # Group structure and partners **Bharat Rasayan is a standalone public company with no subsidiaries - its strategic reach comes from a 30% stake in a Japanese joint venture and deep operational ties with two sister concerns that share common shareholders and management.** - **The Nissan JV is the technology bridge** - in February 2020 the company formed Nissan Bharat Rasayan Private Limited with Nissan Chemical Corporation of Japan, one of Japan’s largest research-based agrochemical firms; Bharat Rasayan holds 30%, Nissan holds 70%, and the entity is building a new factory in India to manufacture technical products using Nissan’s proprietary chemistry. - **B R Agrotech is the largest related-party trading partner** - a company with common shareholders and management, it bought and sold materials worth roughly ₹300 crores with Bharat Rasayan in FY25, providing procurement and sales synergies that reduce turnaround time. - **Bharat Certis Agriscience adds another supply-chain link** - also under common shareholders with a Bharat Rasayan director on its board, it transacted about ₹10 crores in FY25, with planned activity scaling up to an estimated ₹150 crores in FY26. - **No holding company, no subsidiaries** - the company is a single listed entity with a promoter group holding roughly 75% of the equity and a ten-member board split evenly between executive and independent directors.

Documents — Bharat Rasayan Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/fbr3l2w6n8nchsmoaf11mwm2.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/25u9dc62454wvm7hx4skte4y.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/ykopydazjeeoghh3c5u8capa.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/c9ci0n1l2tr7oix96tcwua8k.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/4vpvm59bw3ey5tmhdo47qp8i.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/ek72j3mmetgwxhjo3dsvz755.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/hvltdi7pv74a2e7i2bry9cwu.pdf
  • Q1 FY2025 Quarterly Result (Jun 2024, PDF): https://www.stockscans.in/document/tj9prp8ulg4u3o4ae0pkmoui.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/3ovgqk4wfyagxsvfqj16vsas.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/3tn7j30y52zttgrve7sf0m51.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/7e0u7oe3buc35yqm1m774gig.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/qpagrl94qbrqkld8aikl5hyi.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/fxuffs0n9wq3vmlo56f2h86k.pdf